Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
Allyson Whyte Nowak
ID:
1b839958-2619-30fb-68c4
/
Claimed Record
/
Organization:
Norton Rose Fulbright
Published Works
35 articles
The Ontario Superior Court dismisses a generic manufacturer’s claim for damages under section 8 of the <em>PM(NOC) Regulations</em>
Pharma in Brief ·
May 4, 2023
cite
ONCA Confirms Generics Limited to Section 8 Damages in the Face of an Innovator’s Legitimate Exercise of Rights under the PM(NOC) Regulations
Pharma in Brief ·
August 25, 2022
cite
Federal Court of Appeal Gradually Phases Out Suspension Period
Pharma in Brief ·
June 22, 2021
cite
Federal Court of Appeal Restores Suspension Period
Pharma in Brief ·
April 26, 2021
cite
Ontario Superior Court summarily dismisses Apotex’s novel monetary claims under Statutes of Monopolies, Trademarks Act, and at common law
Pharma in Brief ·
March 18, 2021
cite
Previous
1
2
...
7
Next
Practice Areas
Health Care and Life Sciences
Intellectual Property
Jurisdictions
Canada
North America
United States
